Press Releases

Date Title  
Toggle Summary West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., Jun 18, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.19 per share for the third quarter of 2002 payable August 7, 2002 to shareholders of record July 24, 2002.
West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., Jun 18, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.19 per share for the third quarter of 2002 payable August 7, 2002 to shareholders of record July 24, 2002.
Toggle Summary West Pharmaceutical Services Introduces Packaging System That Combats Drug Counterfeiting
NEW YORK, Jun 4, 2002 (BW HealthWire) -- West Pharmaceutical Services, Inc. (NYSE: WST), Pharmaceutical Systems Division, introduced the new D-I-D(R)(Decoration-Identification-Differentiation) System, a counterfeiting packaging protection program. Drug counterfeiting is a global crime that
West Pharmaceutical Services Introduces Packaging System That Combats Drug Counterfeiting
NEW YORK, Jun 4, 2002 (BW HealthWire) -- West Pharmaceutical Services, Inc. (NYSE: WST), Pharmaceutical Systems Division, introduced the new D-I-D(R)(Decoration-Identification-Differentiation) System, a counterfeiting packaging protection program. Drug counterfeiting is a global crime that
Toggle Summary West Pharmaceutical Services Expands Clearwater Pharmaceutical Closure Production Facility
CLEARWATER, Fla., Jun 4, 2002 (BW HealthWire) -- Scaled Up Operations Respond to Industry Demand for Counterfeit Protection Closures The Pharmaceutical Systems Division of West Pharmaceutical Services, Inc. (NYSE: WST), announced completion of a 20,000-square-foot expansion of its ISO 9002
West Pharmaceutical Services Expands Clearwater Pharmaceutical Closure Production Facility
CLEARWATER, Fla., Jun 4, 2002 (BW HealthWire) -- Scaled Up Operations Respond to Industry Demand for Counterfeit Protection Closures The Pharmaceutical Systems Division of West Pharmaceutical Services, Inc. (NYSE: WST), announced completion of a 20,000-square-foot expansion of its ISO 9002
Toggle Summary Donald E. Morel, Jr. Named West Pharmaceutical Services Chief Executive Officer
LIONVILLE, Pa., Apr 30, 2002 /PRNewswire-FirstCall via COMTEX/ -- William G. Little Continues as Chairman West Pharmaceutical Services, Inc. (NYSE: WST) today announced, effective immediately, the promotion of Donald E. Morel, Jr., Ph.D., 44, to Chief Executive Officer. Dr.
Donald E. Morel, Jr. Named West Pharmaceutical Services Chief Executive Officer
LIONVILLE, Pa., Apr 30, 2002 /PRNewswire-FirstCall via COMTEX/ -- William G. Little Continues as Chairman West Pharmaceutical Services, Inc. (NYSE: WST) today announced, effective immediately, the promotion of Donald E. Morel, Jr., Ph.D., 44, to Chief Executive Officer. Dr.
Toggle Summary West Pharmaceutical Services Announces Annual Meeting Webcast
LIONVILLE, Pa., April 26 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a drug delivery systems company, will hold its annual meeting of shareholders on Tuesday, April 30 at 9:30 a.m. eastern time. The meeting will be conducted at West's global headquarters in Lionville.
West Pharmaceutical Services Announces Annual Meeting Webcast
LIONVILLE, Pa., April 26 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a drug delivery systems company, will hold its annual meeting of shareholders on Tuesday, April 30 at 9:30 a.m. eastern time. The meeting will be conducted at West's global headquarters in Lionville.
Toggle Summary West Pharmaceutical Services, Inc. Announces 2002 First Quarter Results
LIONVILLE, Pa., Apr 18, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today reported earnings per share of $0.42 for the quarter ended March 31, 2002, up from $0.38 in the first quarter of 2001. Excluding the effects of discontinued operations and a
West Pharmaceutical Services, Inc. Announces 2002 First Quarter Results
LIONVILLE, Pa., Apr 18, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today reported earnings per share of $0.42 for the quarter ended March 31, 2002, up from $0.38 in the first quarter of 2001. Excluding the effects of discontinued operations and a
Toggle Summary West Pharmaceutical Services, Inc. to Broadcast Review of First Quarter Earnings Live Over the Internet
LIONVILLE, Pa., Apr 10, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release first quarter financial results before the open of the market on Thursday, April 18, 2002. William G.
West Pharmaceutical Services, Inc. to Broadcast Review of First Quarter Earnings Live Over the Internet
LIONVILLE, Pa., Apr 10, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release first quarter financial results before the open of the market on Thursday, April 18, 2002. William G.
Toggle Summary West Pharmaceutical Services Launches eWestDirect; Web Site is First in the Primary Pharmaceutical Closures Industry to Provide Online Technical Guidance
LIONVILLE, Pa., Apr 8, 2002 (BW HealthWire) -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the launch of eWestDirect.com, the industry's first e-commerce enabled Web site focused on supporting customers with online technical guidance, as well as for buying pharmaceutical
West Pharmaceutical Services Launches eWestDirect; Web Site is First in the Primary Pharmaceutical Closures Industry to Provide Online Technical Guidance
LIONVILLE, Pa., Apr 8, 2002 (BW HealthWire) -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the launch of eWestDirect.com, the industry's first e-commerce enabled Web site focused on supporting customers with online technical guidance, as well as for buying pharmaceutical
Toggle Summary West Promotes Linda Altemus to Chief Financial Officer
LIONVILLE, Pa., Mar 12, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the appointment of Linda R. Altemus as Vice President and Chief Financial Officer. Ms. Altemus, age 50, joined West in May 1997 as Director of Global Information
West Promotes Linda Altemus to Chief Financial Officer
LIONVILLE, Pa., Mar 12, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the appointment of Linda R. Altemus as Vice President and Chief Financial Officer. Ms. Altemus, age 50, joined West in May 1997 as Director of Global Information
Toggle Summary West Pharmaceutical Services Adds Donald Morel, Jr., Ph.D. to Board
LIONVILLE, Pa., Mar 12, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the election of Donald E. Morel, Jr., Ph.D. to its Board of Directors. Dr. Morel fills the vacancy on the Board created by the retirement of Dr. Monroe E. Trout. Dr.
West Pharmaceutical Services Adds Donald Morel, Jr., Ph.D. to Board
LIONVILLE, Pa., Mar 12, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the election of Donald E. Morel, Jr., Ph.D. to its Board of Directors. Dr. Morel fills the vacancy on the Board created by the retirement of Dr. Monroe E. Trout. Dr.
Toggle Summary West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., Mar 11, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors has declared a dividend of $.19 per share for the second quarter of 2002 payable May 1, 2002 to shareholders of record April 17, 2002.
West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., Mar 11, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors has declared a dividend of $.19 per share for the second quarter of 2002 payable May 1, 2002 to shareholders of record April 17, 2002.
Toggle Summary West Pharmaceutical Services, Inc. Announces Fourth Quarter and Full Year 2001 Results
LIONVILLE, Pa., Feb 14, 2002 /PRNewswire-FirstCall via COMTEX/ -- - Net Income From Continuing Operations Up 76% on 11% Increase in Revenue - - Comparable 2002 Earnings Expected to Grow by Between 13% and 19% - West Pharmaceutical Services, Inc. (NYSE: WST) today reported financial results for the
West Pharmaceutical Services, Inc. Announces Fourth Quarter and Full Year 2001 Results
LIONVILLE, Pa., Feb 14, 2002 /PRNewswire-FirstCall via COMTEX/ -- - Net Income From Continuing Operations Up 76% on 11% Increase in Revenue - - Comparable 2002 Earnings Expected to Grow by Between 13% and 19% - West Pharmaceutical Services, Inc. (NYSE: WST) today reported financial results for the
Toggle Summary West Pharmaceutical Services, Inc. To Broadcast Review Of Fourth Quarter And Year-End Earnings Live Over The Internet
LIONVILLE, Pa., Feb 8, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and year-end financial results before the open of the market on Thursday, February 14, 2002. William G.
West Pharmaceutical Services, Inc. To Broadcast Review Of Fourth Quarter And Year-End Earnings Live Over The Internet
LIONVILLE, Pa., Feb 8, 2002 /PRNewswire-FirstCall via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and year-end financial results before the open of the market on Thursday, February 14, 2002. William G.
Toggle Summary West Pharmaceutical Services, Inc. Consolidates Divisions
LIONVILLE, Pa., Dec 6, 2001 /PRNewswire via COMTEX/ -- Sharpens Focus on Growth Markets for Pharmaceutical Technologies West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it will consolidate operations into two divisions, which will be named the Pharmaceutical Systems and Drug
West Pharmaceutical Services, Inc. Consolidates Divisions
LIONVILLE, Pa., Dec 6, 2001 /PRNewswire via COMTEX/ -- Sharpens Focus on Growth Markets for Pharmaceutical Technologies West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it will consolidate operations into two divisions, which will be named the Pharmaceutical Systems and Drug
Toggle Summary West Pharmaceutical Services, Inc. Appoints Michael Myers, Ph.D. As Drug Delivery President
LIONVILLE, Pa., Dec 5, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that Michael Myers, Ph.D., has joined West as President of the Drug Delivery Systems Division. Dr. Myers, age 40, most recently held the position of Executive Vice President,
West Pharmaceutical Services, Inc. Appoints Michael Myers, Ph.D. As Drug Delivery President
LIONVILLE, Pa., Dec 5, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that Michael Myers, Ph.D., has joined West as President of the Drug Delivery Systems Division. Dr. Myers, age 40, most recently held the position of Executive Vice President,
Toggle Summary West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., Dec 4, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.19 per share for the first quarter of 2002 payable February 6, 2002 to shareholders of record January 23, 2002.
West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., Dec 4, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.19 per share for the first quarter of 2002 payable February 6, 2002 to shareholders of record January 23, 2002.
Toggle Summary West Pharmaceutical Services and Novartis Animal Health Extend Oral Vaccine Field Trials and Begin Second Program
LIONVILLE, Pa., Dec 3, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) and Novartis Animal Health Inc. have extended their 1999 development program that involves the delivery of oral vaccines using West's proprietary technologies.
West Pharmaceutical Services and Novartis Animal Health Extend Oral Vaccine Field Trials and Begin Second Program
LIONVILLE, Pa., Dec 3, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) and Novartis Animal Health Inc. have extended their 1999 development program that involves the delivery of oral vaccines using West's proprietary technologies.
Toggle Summary West Pharmaceutical Services, Inc. Completes Sale of Contract Packaging Unit
LIONVILLE, Pa., Nov 30, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today completed the previously announced sale of all of the assets of its contract manufacturing and packaging business, located in Lakewood, NJ, to DPT Lakewood, Inc., an affiliate of DPT
West Pharmaceutical Services, Inc. Completes Sale of Contract Packaging Unit
LIONVILLE, Pa., Nov 30, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today completed the previously announced sale of all of the assets of its contract manufacturing and packaging business, located in Lakewood, NJ, to DPT Lakewood, Inc., an affiliate of DPT
Toggle Summary West Pharmaceutical Services, Inc. Announces Sale of Contract Packaging Unit
LIONVILLE, Pa., Nov 15, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it entered into a definitive agreement for the sale of all of the assets of its contract manufacturing and packaging business, located in Lakewood, NJ, to DPT Lakewood, Inc.,
West Pharmaceutical Services, Inc. Announces Sale of Contract Packaging Unit
LIONVILLE, Pa., Nov 15, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it entered into a definitive agreement for the sale of all of the assets of its contract manufacturing and packaging business, located in Lakewood, NJ, to DPT Lakewood, Inc.,
Toggle Summary West Pharmaceutical Services Launches Novel Single Dose Drug Reconstitution System for Point-of-Care Use
DENVER, Oct. 22 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) introduced Clip'n'Ject(TM), a proprietary and novel system for improving the point-of-care reconstitution and delivery of lyophilized or dry-powder drugs, at the American Association of Pharmaceutical Scientists (AAPS)
West Pharmaceutical Services Launches Novel Single Dose Drug Reconstitution System for Point-of-Care Use
DENVER, Oct. 22 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) introduced Clip'n'Ject(TM), a proprietary and novel system for improving the point-of-care reconstitution and delivery of lyophilized or dry-powder drugs, at the American Association of Pharmaceutical Scientists (AAPS)
Toggle Summary West Pharmaceutical Services, Inc. Announces Third Quarter, Nine Month Results
LIONVILLE, Pa., Oct. 17 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced financial results for the third quarter and nine months ended September 30, 2001. Net income for the third quarter was $5.9 million, or $0.41 per diluted share, compared to $4.6 million, or $0.32
West Pharmaceutical Services, Inc. Announces Third Quarter, Nine Month Results
LIONVILLE, Pa., Oct. 17 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced financial results for the third quarter and nine months ended September 30, 2001. Net income for the third quarter was $5.9 million, or $0.41 per diluted share, compared to $4.6 million, or $0.32
Toggle Summary West Pharmaceutical Services, Inc. to Broadcast Review of Third Quarter Earnings Live Over the Internet
LIONVILLE, Pa., Oct. 15 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release third quarter financial results before the open of the market on Wednesday, October 17, 2001. William G. Little, Chairman and Chief Executive Officer and Dr. Donald E.
West Pharmaceutical Services, Inc. to Broadcast Review of Third Quarter Earnings Live Over the Internet
LIONVILLE, Pa., Oct. 15 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release third quarter financial results before the open of the market on Wednesday, October 17, 2001. William G. Little, Chairman and Chief Executive Officer and Dr. Donald E.
Toggle Summary West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., Oct 5, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. announced that its Board of Directors has declared a dividend of $.19 per share for the fourth quarter of 2001 payable November 7, 2001 to shareholders of record October 24, 2001.
West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., Oct 5, 2001 /PRNewswire via COMTEX/ -- West Pharmaceutical Services, Inc. announced that its Board of Directors has declared a dividend of $.19 per share for the fourth quarter of 2001 payable November 7, 2001 to shareholders of record October 24, 2001.
Toggle Summary West Pharmaceutical Services Initiates U.S. Clinical Trials of Novel Site-Specific Oral Therapy for Gastrointestinal Disorders
LIONVILLE, Pa., Sep 24, 2001 /PRNewswire/ -- Proprietary Oral Delivery System, TARGIT-Budesonide, to Potentially Improve Effectiveness and Reduce Side-Effects for Treatment of Inflammatory Bowel Diseases, Ulcerative Colitis and Crohn's Disease West Pharmaceutical Services, Inc.
West Pharmaceutical Services Initiates U.S. Clinical Trials of Novel Site-Specific Oral Therapy for Gastrointestinal Disorders
LIONVILLE, Pa., Sep 24, 2001 /PRNewswire/ -- Proprietary Oral Delivery System, TARGIT-Budesonide, to Potentially Improve Effectiveness and Reduce Side-Effects for Treatment of Inflammatory Bowel Diseases, Ulcerative Colitis and Crohn's Disease West Pharmaceutical Services, Inc.
Toggle Summary West Pharmaceutical Services, Inc. Announces Death of J. Roffe Wike, II, Director
LIONVILLE, Pa., Sep 13, 2001 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that J. Roffe Wike, II died at home on September 10th, 2001 following a brief illness. Mr. Wike was a member of the Company's Board of Directors for almost 40 years and the son of one of the
West Pharmaceutical Services, Inc. Announces Death of J. Roffe Wike, II, Director
LIONVILLE, Pa., Sep 13, 2001 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that J. Roffe Wike, II died at home on September 10th, 2001 following a brief illness. Mr. Wike was a member of the Company's Board of Directors for almost 40 years and the son of one of the
Toggle Summary West Pharmaceutical Services Announces Successful Completion Of Euro Conversion
LIONVILLE, Pa., Aug. 6 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it has successfully completed conversion of its business processes and systems in the Eurozone from national currencies to the Euro. The company now has the capabilities to offer full business
West Pharmaceutical Services Announces Successful Completion Of Euro Conversion
LIONVILLE, Pa., Aug. 6 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it has successfully completed conversion of its business processes and systems in the Eurozone from national currencies to the Euro. The company now has the capabilities to offer full business
Toggle Summary West Pharmaceutical Services, Inc. Clarifies Statements Regarding Debiotech, S.A. and Debiopharm, S.A
LIONVILLE, Pa., July 24 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today clarified references to Debiotech, S.A. and Debiopharm, S.A. that were contained in recent company press releases. In a release issued July 17, 2001, West Pharmaceutical Services referred to Debiotech, S.A.
West Pharmaceutical Services, Inc. Clarifies Statements Regarding Debiotech, S.A. and Debiopharm, S.A
LIONVILLE, Pa., July 24 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today clarified references to Debiotech, S.A. and Debiopharm, S.A. that were contained in recent company press releases. In a release issued July 17, 2001, West Pharmaceutical Services referred to Debiotech, S.A.
Toggle Summary West Pharmaceutical Services, Inc. Announces Second-Quarter and Six-Month Results
LIONVILLE, Pa., Jul 19, 2001 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the second quarter and six months ended June 30, 2001. Net sales for the second quarter increased 3% to $117.2 million compared to the $113.6 million reported in the second
West Pharmaceutical Services, Inc. Announces Second-Quarter and Six-Month Results
LIONVILLE, Pa., Jul 19, 2001 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced results for the second quarter and six months ended June 30, 2001. Net sales for the second quarter increased 3% to $117.2 million compared to the $113.6 million reported in the second
Toggle Summary West Pharmaceutical Services Secures U.S. Marketing Rights for Novel Single Dose Drug Reconstitution System
LIONVILLE, Pa., July 17 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced the first significant commercial milestone in its new initiative to manufacture and market an advanced single dose delivery drug reconstitution system. Debiopharm, S.A., a Swiss-based pharmaceutical
West Pharmaceutical Services Secures U.S. Marketing Rights for Novel Single Dose Drug Reconstitution System
LIONVILLE, Pa., July 17 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced the first significant commercial milestone in its new initiative to manufacture and market an advanced single dose delivery drug reconstitution system. Debiopharm, S.A., a Swiss-based pharmaceutical
Toggle Summary West Pharmaceutical Services Announces Agreement With Solvay Pharmaceuticals To License Novel Nasal Delivery Technology For Leading Influenza Vaccine
LIONVILLE, Pa., Jul 2, 2001 /PRNewswire/ -- West Pharmaceutical Services' Patented ChiSys(TM) Nasal Delivery System to be Developed for Influvac(TM) Vaccine, Now Used by Millions of Patients in More Than 35 Countries West Pharmaceutical Services, Incorporated (NYSE: WST) today announced completion
West Pharmaceutical Services Announces Agreement With Solvay Pharmaceuticals To License Novel Nasal Delivery Technology For Leading Influenza Vaccine
LIONVILLE, Pa., Jul 2, 2001 /PRNewswire/ -- West Pharmaceutical Services' Patented ChiSys(TM) Nasal Delivery System to be Developed for Influvac(TM) Vaccine, Now Used by Millions of Patients in More Than 35 Countries West Pharmaceutical Services, Incorporated (NYSE: WST) today announced completion
Toggle Summary West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., June 19 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the third quarter of 2001 payable August 1, 2001 to shareholders of record July 18, 2001.
West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., June 19 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the third quarter of 2001 payable August 1, 2001 to shareholders of record July 18, 2001.
Toggle Summary West Pharmaceutical Services, Inc. Announces Promotion of Linda R. Altemus To Vice President, Finance and Administration
LIONVILLE, Pa., May 11 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the promotion of Linda R. Altemus, 49, to the position of Vice President, Finance and Administration, effective June 30, 2001. In her new role, Ms. Altemus will oversee the Company's financial and
West Pharmaceutical Services, Inc. Announces Promotion of Linda R. Altemus To Vice President, Finance and Administration
LIONVILLE, Pa., May 11 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the promotion of Linda R. Altemus, 49, to the position of Vice President, Finance and Administration, effective June 30, 2001. In her new role, Ms. Altemus will oversee the Company's financial and
Toggle Summary West Pharmaceutical Services Concludes Strategic Review
LIONVILLE, Pa., May 1 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the conclusion of its review of strategic alternatives which it was conducting with the assistance of its financial advisor UBS Warburg LLC. The Board of Directors concluded that there is a growing
West Pharmaceutical Services Concludes Strategic Review
LIONVILLE, Pa., May 1 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the conclusion of its review of strategic alternatives which it was conducting with the assistance of its financial advisor UBS Warburg LLC. The Board of Directors concluded that there is a growing
Toggle Summary West Pharmaceutical Services Announces Improved First Quarter Results
LIONVILLE, Pa., April 19 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced improved results for the first quarter ended March 31, 2001. Net income for the first quarter was $5.4 million, or $0.38 per share, compared with net income of $5.1 million, or $0.35 per share,
West Pharmaceutical Services Announces Improved First Quarter Results
LIONVILLE, Pa., April 19 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced improved results for the first quarter ended March 31, 2001. Net income for the first quarter was $5.4 million, or $0.38 per share, compared with net income of $5.1 million, or $0.35 per share,
Toggle Summary West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., March 12 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the second quarter of 2001 payable May 2, 2001 to shareholders of record April 18, 2001.
West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., March 12 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the second quarter of 2001 payable May 2, 2001 to shareholders of record April 18, 2001.
Toggle Summary West Pharmaceutical Services, Inc. Announces Fourth Quarter and Full Year 2000 Results
LIONVILLE, Pa., Feb. 27 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today reported financial results for the fourth quarter and year-ended December 31, 2000. The results are consistent with guidance provided by management on January 29, 2001.
West Pharmaceutical Services, Inc. Announces Fourth Quarter and Full Year 2000 Results
LIONVILLE, Pa., Feb. 27 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today reported financial results for the fourth quarter and year-ended December 31, 2000. The results are consistent with guidance provided by management on January 29, 2001.
Toggle Summary West Pharmaceutical Services to Present at UBS Warburg Global Healthcare Services Conference
LIONVILLE, Pa., Feb. 5 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it will present at the UBS Warburg Global Healthcare Services Conference on Tuesday, February 6, 2001 at 2:00 p.m. at the New York Plaza Hotel. Dr. Donald E.
West Pharmaceutical Services to Present at UBS Warburg Global Healthcare Services Conference
LIONVILLE, Pa., Feb. 5 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it will present at the UBS Warburg Global Healthcare Services Conference on Tuesday, February 6, 2001 at 2:00 p.m. at the New York Plaza Hotel. Dr. Donald E.
Toggle Summary West Pharmaceutical Services Comments on Expected Fourth Quarter and Full Year 2000 Results
LIONVILLE, Pa., Jan. 29 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today commented on expected results for the fourth quarter and year ended December 31, 2000. As disclosed previously, soft market conditions and project delays resulted in lower sales volumes in the contract
West Pharmaceutical Services Comments on Expected Fourth Quarter and Full Year 2000 Results
LIONVILLE, Pa., Jan. 29 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today commented on expected results for the fourth quarter and year ended December 31, 2000. As disclosed previously, soft market conditions and project delays resulted in lower sales volumes in the contract
Toggle Summary West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., Dec. 12 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the first quarter of 2001 payable February 7, 2001 to shareholders of record January 24, 2001.
West Pharmaceutical Services, Inc. Announces Dividend
LIONVILLE, Pa., Dec. 12 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has declared a dividend of $.18 per share for the first quarter of 2001 payable February 7, 2001 to shareholders of record January 24, 2001.
Toggle Summary West Pharmaceutical Services, Inc. Announces Corporate Initiatives To Streamline Operations
LIONVILLE, Pa., Nov. 16 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors approved corporate initiatives designed to streamline operations and improve efficiencies. The Company stated that these initiatives are independent of UBS Warburg's
West Pharmaceutical Services, Inc. Announces Corporate Initiatives To Streamline Operations
LIONVILLE, Pa., Nov. 16 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors approved corporate initiatives designed to streamline operations and improve efficiencies. The Company stated that these initiatives are independent of UBS Warburg's